Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Non-cash Items (2022 - 2025)

Coya Therapeutics' Non-cash Items history spans 4 years, with the latest figure at $2.4 million for Q3 2025.

  • For Q3 2025, Non-cash Items fell 37.95% year-over-year to $2.4 million; the TTM value through Sep 2025 reached $2.4 million, down 37.95%, while the annual FY2024 figure was $5.4 million, 200.0% up from the prior year.
  • Non-cash Items for Q3 2025 was $2.4 million at Coya Therapeutics, down from $7.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $8.4 million in Q1 2025 and bottomed at $346417.0 in Q4 2022.
  • The 4-year median for Non-cash Items is $1.5 million (2023), against an average of $2.8 million.
  • The largest annual shift saw Non-cash Items crashed 49.72% in 2024 before it skyrocketed 1445.83% in 2025.
  • A 4-year view of Non-cash Items shows it stood at $346417.0 in 2022, then soared by 419.6% to $1.8 million in 2023, then skyrocketed by 200.0% to $5.4 million in 2024, then plummeted by 55.02% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for COYA's Non-cash Items are $2.4 million (Q3 2025), $7.1 million (Q2 2025), and $8.4 million (Q1 2025).